SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-014533
Filing Date
2020-06-09
Accepted
2020-06-09 17:27:07
Documents
5
Period of Report
2020-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea122850-8k_calmaretherap.htm 8-K 21350
2 LETTER, DATED JUNE 1, 2020, FROM U.S. FEDERAL SUPPLY SCHEDULE SERVICE TO CALMARE ea122850ex10-1_calmaretherap.htm EX-10.1 8664
3 PRESS RELEASE, DATED JUNE 9, 2020 ea122850ex99-1_calmaretherap.htm EX-99.1 6852
4 GRAPHIC ex10-1_001.jpg GRAPHIC 9119
5 GRAPHIC image_001.jpg GRAPHIC 12624
  Complete submission text file 0001213900-20-014533.txt   68435
Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824
Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044
CALMARE THERAPEUTICS Inc (Filer) CIK: 0000102198 (see all company filings)

IRS No.: 362664428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-08696 | Film No.: 20952829
SIC: 3841 Surgical & Medical Instruments & Apparatus